Vor Biopharma VOR
NASDAQ VOR
$20.09 +0.53 (+2.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Vor Biopharma (VOR) Research & Development (2020 - 2026)

Updated

Vor Biopharma (VOR) recorded Research & Development of $34.53 million in Q3 2026, up 144.2% from $14.14 million a year earlier and up 33.2% from the prior quarter.

Analysis

Vor Biopharma (VOR) Research & Development (2020 - 2026) Analysis & Trends

On a TTM basis, Vor Biopharma's Research & Development came in at $97.24 million as of Sep 30, 2026, down 70.3% year-over-year; for FY2025, it came in at $321.53 million, up 244.6% from FY2024.

  • Annual Research & Development has a five-year compound annual growth rate of 59.0% (FY2020 to FY2025).
  • Across earlier years, Research & Development came in at $93.31 million in FY2024 (-1.1%), $94.32 million in FY2023 (+46.1%), $64.55 million in FY2022 (+35.8%) and $47.53 million in FY2021 (+50.3%).
  • The Q3 2026 figure is the highest quarterly Research & Development since Q2 2025.
  • On a year-over-year basis, Research & Development rose in three of the last seven quarters, with an average decline of 1.2%.
  • Peak year-over-year performance for Research & Development in the last five years was growth of 144.2% in Q3 2026, against a decline of 90.1% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $25.92 million (Q2 2026), $17.6 million (Q1 2026) and $19.19 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 4.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.57 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.89 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.61 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.02 Bn
10 Vor Biopharma 1.20 Bn -692.85 Mn - 34.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 34.53 Mn
Jun 30, 2026 25.92 Mn
Mar 31, 2026 17.60 Mn
Dec 31, 2025 19.19 Mn
Sep 30, 2025 14.14 Mn
Jun 30, 2025 261.50 Mn
Mar 31, 2025 26.70 Mn
Dec 31, 2024 25.35 Mn
Sep 30, 2024 21.82 Mn
Jun 30, 2024 21.82 Mn
Mar 31, 2024 24.32 Mn
Dec 31, 2023 20.90 Mn
Sep 30, 2023 27.61 Mn
Jun 30, 2023 23.90 Mn
Mar 31, 2023 21.92 Mn
Dec 31, 2022 17.06 Mn
Sep 30, 2022 16.88 Mn
Jun 30, 2022 15.33 Mn
Mar 31, 2022 15.28 Mn
Dec 31, 2021 12.69 Mn
API Access

Vor Biopharma Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=VOR&period=max&api_key=YOUR_API_KEY